These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26107182)

  • 1. Circulating Lipids Are Associated with Alcoholic Liver Cirrhosis and Represent Potential Biomarkers for Risk Assessment.
    Meikle PJ; Mundra PA; Wong G; Rahman K; Huynh K; Barlow CK; Duly AM; Haber PS; Whitfield JB; Seth D
    PLoS One; 2015; 10(6):e0130346. PubMed ID: 26107182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Utility of Commonly Used Laboratory Tests to Screen for Excessive Alcohol Use in Clinical Practice.
    Gough G; Heathers L; Puckett D; Westerhold C; Ren X; Yu Z; Crabb DW; Liangpunsakul S
    Alcohol Clin Exp Res; 2015 Aug; 39(8):1493-500. PubMed ID: 26110815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What's in Metabolomics for Alcoholic Liver Disease?
    Suciu AM; Crisan DA; Procopet BD; Radu CI; Socaciu C; Tantau MV; Stefanescu HO; Grigorescu M
    J Gastrointestin Liver Dis; 2018 Mar; 27(1):51-58. PubMed ID: 29557415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol consumption pattern and serum lipids in alcoholic cirrhosis and pancreatitis. A comparative study.
    Stigendal L; Olsson R
    Scand J Gastroenterol; 1984 Jul; 19(5):582-7. PubMed ID: 6474079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of laboratory tests for cirrhosis and for alcohol use, in the context of alcoholic cirrhosis.
    Whitfield JB; Masson S; Liangpunsakul S; Hyman J; Mueller S; Aithal G; Eyer F; Gleeson D; Thompson A; Stickel F; Soyka M; Daly AK; Cordell HJ; Liang T; Foroud T; Lumeng L; Pirmohamed M; Nalpas B; Bence C; Jacquet JM; Louvet A; Moirand R; Nahon P; Naveau S; Perney P; Podevin P; Haber PS; Seitz HK; Day CP; Mathurin P; Morgan TM; Seth D;
    Alcohol; 2018 Feb; 66():1-7. PubMed ID: 29277282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers.
    Whitfield JB; Zhu G; Madden PAF; Montgomery GW; Heath AC; Martin NG
    Alcohol Clin Exp Res; 2019 Mar; 43(3):473-482. PubMed ID: 30589442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of alcohol consumption on liver stiffness measured by transient elastography.
    Bardou-Jacquet E; Legros L; Soro D; Latournerie M; Guillygomarc'h A; Le Lan C; Brissot P; Guyader D; Moirand R
    World J Gastroenterol; 2013 Jan; 19(4):516-22. PubMed ID: 23382630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of novel serum markers of fibrosis and angiogenesis in patients with alcoholic liver cirrhosis.
    Prystupa A; Kiciński P; Luchowska-Kocot D; Nowicki G; Dzida G; Myśliński W; Zakrzewski M; Mosiewicz J; Panasiuk L
    Ann Agric Environ Med; 2020 Dec; 27(4):568-573. PubMed ID: 33356062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of the Enhanced Liver Fibrosis Test vs FibroTest, Elastography, and Indirect Markers in Detection of Advanced Fibrosis in Patients With Alcoholic Liver Disease.
    Thiele M; Madsen BS; Hansen JF; Detlefsen S; Antonsen S; Krag A
    Gastroenterology; 2018 Apr; 154(5):1369-1379. PubMed ID: 29317276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study.
    Vali Y; Lee J; Boursier J; Petta S; Wonders K; Tiniakos D; Bedossa P; Geier A; Francque S; Allison M; Papatheodoridis G; Cortez-Pinto H; Pais R; Dufour JF; Leeming DJ; Harrison SA; Chen Y; Cobbold JF; Pavlides M; Holleboom AG; Yki-Jarvinen H; Crespo J; Karsdal M; Ostroff R; Zafarmand MH; Torstenson R; Duffin K; Yunis C; Brass C; Ekstedt M; Aithal GP; Schattenberg JM; Bugianesi E; Romero-Gomez M; Ratziu V; Anstee QM; Bossuyt PM;
    Lancet Gastroenterol Hepatol; 2023 Aug; 8(8):714-725. PubMed ID: 36958367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the severity of liver cirrhosis on the level of lipids and lipoproteins.
    Chrostek L; Supronowicz L; Panasiuk A; Cylwik B; Gruszewska E; Flisiak R
    Clin Exp Med; 2014 Nov; 14(4):417-21. PubMed ID: 24122348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating lipocalin 2 is neither related to liver steatosis in patients with non-alcoholic fatty liver disease nor to residual liver function in cirrhosis.
    Meier EM; Pohl R; Rein-Fischboeck L; Schacherer D; Eisinger K; Wiest R; Krautbauer S; Buechler C
    Cytokine; 2016 Sep; 85():45-50. PubMed ID: 27288631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasonography for diagnosis of alcoholic cirrhosis in people with alcoholic liver disease.
    Pavlov CS; Casazza G; Semenistaia M; Nikolova D; Tsochatzis E; Liusina E; Ivashkin VT; Gluud C
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD011602. PubMed ID: 26934429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated carboxy terminal cross linked telopeptide of type I collagen in alcoholic cirrhosis: relation to liver and kidney function and bone metabolism.
    Møller S; Hansen M; Hillingso J; Jensen JE; Henriksen JH
    Gut; 1999 Mar; 44(3):417-23. PubMed ID: 10026331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of cytokines in alcoholic liver cirrhosis and pancreatitis.
    Szuster-Ciesielska A; Daniluk J; Kandefer-Zerszeń M
    Arch Immunol Ther Exp (Warsz); 2000; 48(4):301-7. PubMed ID: 11059648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the epsilon 2 allele of APOE gene to hypertriglyceridemia and to early-onset alcoholic cirrhosis.
    Hernández-Nazará ZH; Ruiz-Madrigal B; Martínez-López E; Roman S; Panduro A
    Alcohol Clin Exp Res; 2008 Apr; 32(4):559-66. PubMed ID: 18241317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism of alcohol dehydrogenase, alcohol and aldehyde dehydrogenase activities: implication in alcoholic cirrhosis in white patients. The French Group for Research on Alcohol and Liver.
    Poupon RE; Nalpas B; Coutelle C; Fleury B; Couzigou P; Higueret D
    Hepatology; 1992 Jun; 15(6):1017-22. PubMed ID: 1592339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease.
    Lombardi R; Buzzetti E; Roccarina D; Tsochatzis EA
    World J Gastroenterol; 2015 Oct; 21(39):11044-52. PubMed ID: 26494961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening.
    Simão A; Madaleno J; Silva N; Rodrigues F; Caseiro P; Costa JN; Carvalho A
    BMC Gastroenterol; 2015 Jun; 15():73. PubMed ID: 26122937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum ubiquitin levels in patients with alcoholic liver disease.
    Takagi M; Yamauchi M; Toda G; Takada K; Hirakawa T; Ohkawa K
    Alcohol Clin Exp Res; 1999 Apr; 23(4 Suppl):76S-80S. PubMed ID: 10235284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.